UK researchers have launched a study to assess the potential benefits of whole-genome sequencing in primary health care.

Institute of Cancer Research professor Ros Eeles and 90 Sloane Street general practitioner Michael Sandberg will lead the initiative, 90S Study.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Patient volunteers from 90 Sloane Street will be recruited for the study.

Furthermore, the study will involve experts of The Institute of Cancer Research (ICR) and The Royal Marsden, as well as cardiologists of Royal Brompton Hospital.

The study will be conducted under the lead of 90 Sloane Street Genetic centre, a collaborative team of five consultant geneticists.

If the study is successful, it could mean a significant step towards the regular use of genetic testing to manage the future health of patients in the NHS.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Initially, 20 patients will be studied to monitor the physiological effects of genome screening as part of a study funded by donations to the ICR.

The study will have support from the NIHR Biomedical Research Centre at The Royal Marsden and the ICR and 90 Sloane Street.

The study will later be expanded to around 1,000 patients, who will be initially recruited at 90 Sloane Street and then at NHS GP practices.

Under the initiative, researchers will evaluate the complete genetic code of those attending a GP surgery, reporting on around 600 separate genetic changes linked with disease and how patients respond to or metabolise some medicines.

The study is looking for ‘actionable gene alterations’ and if identified, it would require a change in choices for an individual such as lifestyle improvements, specific screening and targeted treatments.